Trial intelligence / Profile preview

Ticagrelor vs Clopidogrel in ACS (PLATO)

NCT00391872Phase 3Completed

Sponsor
AstraZeneca
Start
Oct 2006
Primary completion
Mar 2009
Modality
Small Molecules
Countries
44
01

Overview

A Phase 3 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by AstraZeneca. Started Oct 2006; status: completed.

02

Drugs

ticagrelor
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT00391872.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00391872.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call